|
Latest Reports
|
| Date |
Description |
Country |
Analyst |
Download |
|
|
| 05-Feb-2024 |
Report Review of January 2024 |
HongKong/China |
Research Team |
 |
| 24-May-2023 |
Bloomage Biotechnology (688363.SH) - The leader of hyaluronic acid, covering the whole industry chain |
HongKong/China |
Research Team |
|
| 23-Feb-2023 |
Perfect Medical (1830.HK) - 1HFY2023 results under pressure, resumption of normal life and border reopening would revive business |
HongKong/China |
Eric Li |
|
| 02-Jun-2022 |
Report Review of May 2022 |
HongKong/China |
Research Team |
|
| 25-May-2022 |
CR Pharmaceutical (3320.HK) - Promote digital transformation and M&A cooperation to create competitive advantage through innovation and differentiation |
HongKong/China |
Margaret Li |
|
| 21-Feb-2020 |
GENERTEC UNI MEDICAL (2666.HK) Transformation of diversified medical service is progressing steadily, refocus recommended |
HongKong/China |
Judy Li |
|
| 13-Feb-2020 |
FRONTAGE (1521.HK) Covering both China and the US markets, Professional Advantages of "Two Countries, One System" |
HongKong/China |
Judy Li |
|
| 21-Jan-2020 |
CMS (867.HK) Innovative Development and Transformation Continues |
HongKong/China |
Judy Li |
|
| 03-Jan-2020 |
SH Pharma (2607.HK) Rapid growth in core segments, promising in innovation transformations |
HongKong/China |
Judy Li |
|
| 26-Nov-2019 |
CR PHARMA (3320.HK) Develop Segments Cooperation, Improve Business Synergy |
HongKong/China |
Judy Li |
|
| 06-Nov-2019 |
Hengan (1044.HK) Sanitary napkin business is expected to improve in 2H, e-commerce and other businesses grow fast |
HongKong/China |
Eric Li |
|
| 29-Oct-2019 |
SINOPHARM ACCORD (000028.SZ) Results in line with expectations, revenue remains high growth |
HongKong/China |
Judy Li |
|
| 22-Oct-2019 |
CMS (867.HK) Leading Pharmaceutical Marketing and Promotion Company |
HongKong/China |
Judy Li |
|
| 02-Oct-2019 |
CR PHARMA (3320.HK) Distribution Business of 1H2019 Keeps Stable |
HongKong/China |
Judy Li |
|
| 03-Sep-2019 |
SINOPHARM ACCORD (000028.SZ) Distribution Business Exceeds Expectations, Retail Stores Continue Expanding |
HongKong/China |
Judy Li |
|
| 05-Aug-2019 |
CR PHARMA (3320.HK)
China`s Leading Comprehensive Pharmaceutical Enterprise, Organic Growth and External Acquisition Boost Growth |
HongKong/China |
Judy Li |
|
| 26-Jun-2019 |
SINOPHARM ACCORD (000028.SZ) Leading Company in Pharmaceutical Industry, “Wholesale and Retail Integration” Boost Growth |
HongKong/China |
Judy Li |
|
| 22-Feb-2019 |
Ali Health (241.HK) Fast growing e-commerce business with expected synergies from online and offline |
HongKong/China |
Margaret Li |
|
| 30-Jan-2019 |
CR Pharmaceutical (3320.HK) Acquiring New Drug Distribution Rights and Seeking to Enhance Competitiveness in Biopharmaceutical Field |
HongKong/China |
Margaret Li |
|
| 15-Jan-2019 |
CSPC Pharmaceutical (1093.HK) Some drugs may face price-cut risks while current valuation is attractive enough |
HongKong/China |
Margaret Li |
|
| 27-Dec-2018 |
CHINA TCM (570.HK) Leading CTCMG Player Expanding Nationally; Production Capacity of TCM Decoction Pieces Ramp Up |
HongKong/China |
Margaret Li |
|
| 10-Dec-2018 |
CHARMACY PHARM (2289.HK) Company Visit Note of Foshan Logistic Center |
HongKong/China |
Margaret Li |
|
| 23-Nov-2018 |
China Medical System (867.HK) Drug Tender Leading to ASP Drop and New Acquisition to Enrich Pipeline |
HongKong/China |
Margaret Li |
|
| 06-Nov-2018 |
Universal Medical (2666.HK) An Up-and-Coming Comprehensive Healthcare Group with Solid Growth during First Three Quarters |
HongKong/China |
Margaret Li |
|
| 30-Oct-2018 |
Shanghai Pharma (2607.HK) Solid Q3 Results and Further integration of Cardinal |
HongKong/China |
Margaret Li |
|
|
|